Trial Profile
A twelve-week, multicentre, double blind, randomised, parallel group, clinical study to assess the antihypertensive efficacy of delapril 15 mg b.i.d. and 30 mg b.i.d. versus lisinopril and placebo.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 May 2011
Price :
$35
*
At a glance
- Drugs Delapril (Primary) ; Lisinopril
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms DELPHY
- Sponsors Chiesi
- 31 May 2011 New trial record